510(k) K161817

Tina-quant Cystatin C Gen.2 by Roche Diagnostics Operations (Rdo) — Product Code NDY

K161817 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Operations (Rdo) for the device "Tina-quant Cystatin C Gen.2". The FDA issued a decision of Substantially Equivalent on Jul 27, 2016. The device falls under product code NDY (Test, Cystatin C), a Class II device regulated under 21 CFR 862.1225. Roche Diagnostics Operations (Rdo) has 13 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jul 27, 2016
Date Received
Jul 1, 2016
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Test, Cystatin C
Device Class
Class II
Regulation Number
862.1225
Review Panel
CH
Submission Type
510(k)

Need the full FDA record for Roche Diagnostics Operations (Rdo)? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K161817. Report a data issue: hello@regdatalab.com.